Our results combined with empirical clinical evidence suggest that the absence of respiratory depression by tramadol correlates to sparing of βarrestin2 recruitment by its active metabolite, desmetramadol, newly identified herein as a potent G-protein biased human MOR agonist. This evidence concerns the gene OPRM1 and Respiratory insufficiency due to muscle weakness.